PMA device
GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
W. L. Gore & Associates, Inc. · Endovascular System For Treatment Of Thoracoabdominal And Pararenal Aortic Lesions (QZK, Class III) · First FDA decision Jan 12, 2024, newest Jan 15, 2026Aortic aneurysm and dissection
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
7
PMA pathway
Device trials
17
Naming "GORE EXCLUDER"
MAUDE reports
796
Brand "GORE EXCLUDER", since 2015
PubMed studies
251
Mentioning "GORE EXCLUDER"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 7 decisions filed under this name.
- GORE® EXCLUDER® Thoracoabdominal Branch EndoprosthesisPMA supplement
P230023-S010 · Decided Jan 15, 2026 · 153 days after receipt · Normal 180 Day Track No User Fee
Device type: Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions (QZK) · Cardiology
P230023-S006 · Decided May 20, 2025 · 179 days after receipt · Normal 180 Day Track
Device type: Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions (QZK) · Cardiology
- GORE® EXCLUDER® Thoracoabdominal Branch EndoprosthesisPMA supplement
P230023-S005 · Decided Nov 18, 2024 · 31 days after receipt · Normal 180 Day Track No User Fee
Device type: Endovascular system for treatment of thoracoabdominal and pararenal aortic lesions (QZK) · Cardiology
3 more FDA decisions with a free account
Older decisions: P230023
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "GORE EXCLUDER", any status and sponsor, newest update first.
- Evaluation of the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis in the Treatment of Thoracoabdominal and Pararenal Aortic AneurysmsActive, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT03728985 · 102 participants · Start Jun 17, 2019 · Primary completion Jan 4, 2023
Device: GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis · For: Thoracoabdominal Aortic Aneurysm
Sites: Birmingham, Alabama; Scottsdale, Arizona; Los Angeles, California · 44 sites in all
- GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval StudyActive, not recruiting
W.L.Gore & AssociatesNot on our public-company list
NCT06578741 · 310 participants · Start Nov 25, 2024 · Primary completion Jun 25, 2027
Device: GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) · For: Abdominal Aortic Aneurysm; Pararenal Aortic Aneurysm; Thoracoabdominal Aortic Aneurysm
Sites: Stanford, California
- Endurant Stent Graft System vs Excluder Endoprothesis: ADVANCE TrialPivotal-lookingRecruiting
Medtronic CardiovascularPublic (MDT)
NCT05378347 · 600 participants (planned) · Start Jan 5, 2023 · Primary completion May 2027
Device: Medtronic Endurant II or Endurant IIs Stent Graft System; Gore Excluder or Gore/ Excluder Conformable AAA Endoprosthesis · For: Abdominal Aortic Aneurysm; Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder); Abdominal Aortic Aneurysm >= 5.0 Centimeters in Female (Disorder)
Sites: Loma Linda, California; Newport Beach, California; Orange, California · 68 sites in all
14 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "GORE EXCLUDER", and for the whole product code for context.
This brand
796 reports: 58 malfunction, 703 injury, 33 death
Whole product code QZK
174 reports: 19 malfunction, 132 injury, 23 death
Newest reports for this brand
50809720 · Received Sep 17, 2026 · Event dated Jul 8, 2026
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Device problem as coded: Premature Activation; Manufacturing, Packaging or Shipping Problem
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
24855838 · Received Apr 13, 2026 · Event dated Apr 1, 2026
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: Hemorrhage/Blood Loss/Bleeding; Low Blood Pressure/ Hypotension
23989436 · Received Jan 7, 2026 · Event dated Mar 20, 2025
Device type: System, Endovascular Graft, Aortic Aneurysm Treatment (MIH)
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "GORE EXCLUDER"[tiab]. The summary above synthesizes these.
- Collapsed bifurcated modular infrarenal endograft.
Rathore A, Gloviczki P, Oderich GS, et al. · J Vasc Surg · 2019Case Reports
- Which Endovascular Aneurysm Repair Graft Should I Have?
Narayanan A, Khashram M · Eur J Vasc Endovasc Surg · 2024Editorial
- Reversed Gore Excluder conformable main body as a conduit between branched stent graft limb, common iliac artery, and renal artery.
Aho PS, Björkman P, Venermo M · J Vasc Surg Cases Innov Tech · 2024
- Long Term Outcomes of the Gore Excluder Low Permeability Endoprosthesis for the Treatment of Infrarenal Aortic Aneurysms.
Smorenburg SPM, de Bruin JL, Zeebregts CJ, et al. · Eur J Vasc Endovasc Surg · 2024Multicenter Study
- Endoleak type IIIb not always recognized.
Tayeh M, Sharkawy M, Aswad A, et al. · J Vasc Surg Cases Innov Tech · 2026Case Reports
- Outcomes of the Gore® Excluder® Iliac Branch Endoprosthesis Using Self Expanding or Balloon-Expandable Stent Grafts for the Internal Iliac Artery Component.
Cortolillo NS, Guerra A, Murphy E, et al. · J Endovasc Ther · 2024Comparative Study
- Side-by-side deployment of gore excluder legs at a narrow terminal aorta for endovascular aneurysm repair.
Hohri Y, Kawajiri H, Kanda K, et al. · J Artif Organs · 2024
- Emergent endovascular treatment options for thoracoabdominal aortic aneurysm.
Grandi A, Melloni A, D'Oria M, et al. · Semin Vasc Surg · 2023Review
- Physician-Modified Endovascular Gore Excluder Graft (Handmade Modified) for Complex Abdominal Aortic Aneurysm: A Step-by-Step Approach.
Lopez-Pena G, Garcia-Alva R, Laparra-Escareno H, et al. · Vasc Endovascular Surg · 2020
- A modified candy-plug technique to occlude false lumen in aortic dissection.
Palm E, Valtola A, Manninen H, et al. · CVIR Endovasc · 2022
- Five-year results of the LEOPARD trial of commercially available endografts.
Kwolek CJ, Ouriel K, Stucky FS, et al. · J Vasc Surg · 2023Randomized Controlled Trial, Multicenter Study
- The Gore Excluder endograft device for the treatment of abdominal aortic aneurysms.
Sayeed S, Marone LK, Makaroun MS · J Cardiovasc Surg (Torino) · 2006Review
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.